رجوع
نطاق اليوم
KWD 17.32
KWD 17.94
نطاق 52 أسبوعًا
KWD 16.10
KWD 30.48
حجم التداول
2,408,487
متوسط 50 يوم / 200 يوم
KWD 21.38
/
KWD 22.48
الإغلاق السابق
KWD 17.21
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | 100.3 | 0.4 |
| P/B | 6.1 | 2.9 |
| ROE % | 7.5 | 3.8 |
| Net Margin % | 2.2 | 3.9 |
| Rev Growth 5Y % | 97.1 | 10.0 |
| D/E | 1.3 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 33.500
+90.7%
Low: KWD 19.000
High: KWD 52.000
ربحية السهم المستقبلية
-KWD 1.123
الإيرادات المقدّرة
860 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 2.482
KWD 2.146 – KWD 2.803
|
1.5 B | 8 |
| FY2029 |
KWD 1.504
KWD 1.300 – KWD 1.698
|
1.4 B | 10 |
| FY2028 |
KWD 1.182
-KWD 0.932 – KWD 7.955
|
1.3 B | 18 |
النقاط الرئيسية
Revenue grew 97.06% annually over 5 years — strong growth
Generating 45.01M in free cash flow
P/E of 100.32 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 68.60%
Cash machine — converts 201.06% of earnings into free cash flow
Capital efficient — spends only 0.03% of revenue on capex
النمو
Revenue Growth (5Y)
97.06%
Revenue (1Y)28.46%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
7.48%
ROIC4.85%
Net Margin2.23%
Op. Margin5.52%
الأمان
Debt / Equity
1.31
Current Ratio3.14
Interest Coverage1.25
التقييم
P/E Ratio
100.32
P/B Ratio6.07
EV/EBITDA40.86
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 28.46% | Revenue Growth (3Y) | 59.09% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 97.06% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.00B | Net Income (TTM) | 22.39M |
| ROE | 7.48% | ROA | 2.08% |
| Gross Margin | 89.81% | Operating Margin | 5.52% |
| Net Margin | 2.23% | Free Cash Flow (TTM) | 45.01M |
| ROIC | 4.85% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.31 | Current Ratio | 3.14 |
| Interest Coverage | 1.25 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 100.32 | P/B Ratio | 6.07 |
| P/S Ratio | 2.24 | PEG Ratio | -1.27 |
| EV/EBITDA | 40.86 | Dividend Yield | 0.00% |
| Market Cap | 2.25B | Enterprise Value | 2.26B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1.00B | 781.37M | 396.59M | 75.42M | 66.56M |
| Net Income | 22.39M | -197.88M | -528.63M | -652.17M | -746.35M |
| EPS (Diluted) | 0.18 | -1.60 | -4.45 | -6.15 | -8.84 |
| Gross Profit | 901.55M | 663.64M | 338.08M | 69.79M | 61.36M |
| Operating Income | 55.43M | -164.98M | -517.12M | -594.61M | -536.28M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.08B | 885.05M | 788.73M | 760.22M | 881.77M |
| Total Liabilities | 705.11M | 656.51M | 594.21M | 590.35M | 683.10M |
| Shareholders' Equity | 370.15M | 228.54M | 194.52M | 169.87M | 198.66M |
| Total Debt | 486.31M | 469.78M | 110.93M | 112.71M | 210.22M |
| Cash & Equivalents | 467.76M | 411.29M | 351.19M | 551.80M | 640.19M |
| Current Assets | 1.01B | 788.95M | 766.33M | 719.52M | 824.05M |
| Current Liabilities | 323.60M | 185.51M | 247.59M | 167.61M | 131.85M |